Tranexamic Acid (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Tranexamic Acid drug offered from Cadila Healthcare Limited. This Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
| NON-PROPRIETARY NAME: | Tranexamic Acid |
| SUBSTANCE NAME: | TRANEXAMIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-10-04 |
| END MARKETING DATE: | 0000-00-00 |
Tranexamic Acid HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tranexamic Acid from Cadila Healthcare Limited |
| LABELER NAME: | Cadila Healthcare Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/mL) |
| START MARKETING DATE: | 2017-10-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70771-1085_158dd8a0-c42e-40ef-bcbe-ae33186b6586 |
| PRODUCT NDC: | 70771-1085 |
| APPLICATION NUMBER: | ANDA205228 |
Other TRANEXAMIC ACID Pharmaceutical Manufacturers / Labelers:
